Trademark Search in Canada

ENGTR1S

View On IC.GC.CA

REGISTERED

on 25 Oct 2024

TM5 Status

LIVE/REGISTRATION/Issued and Active

Your registration has been issued and is active. You can now use the TM5 mark.

Last Applicant/ Owned by

GENTIBIO INC.

150 CambridgePark Drive, 9th FloorCambridge MA 02140

Serial Number

2168727 filed on 14^th Jan 2022

Registration Number

TMA1265361 registered on 25^th Oct 2024

Registration expiry Date

14^th Jan 2032

Correspondent Address

KELLY LYNNE MOFFATT

(OSLER, HOSKIN & HARCOURT LLP)BOX 501 FIRST CANADIAN PLACETORONTO

ONTARIO

M5X1B8

ENGTR1S

Trademark usage description

gene therapy products, namely, engineered cell platforms for immunotherapy purposes; pharmaceutical preparations for use in the treatment of autoimmun Read More

Classification Information

Class [005]
Gene therapy products, namely, engineered cell platforms for immunotherapy purposes; pharmaceutical preparations for use in the treatment of autoimmune diseases and disorders, autoinflammatory diseases and disorders, alloimmune diseases and disorders and allergic diseases and disorders.

Classification kind code

Class [040]
Custom manufacture of pharmaceuticals for others; custom manufacturing and engineering of biological cells.

Classification kind code

Class [042]
Scientific research, namely, analysis of human and animal tissues and cells for scientific research purposes; scientific research in the field of genetics; scientific research in the field of genetics and genetic engineering; scientific research in the field of immune sequencing; scientific research in the field of autoimmune, alloimmune, inflammatory and allergic diseases; pharmaceutical research; medical research; technological consultation services in the fields of manufacturing pharmaceuticals and manufacturing engineering of biological cells; laboratory research services in the field of immunology and cellular engineering.

Classification kind code

Mark Details

Serial Number

2168727

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 22 on 15^th Jun 2023	Search Recorded
Submitted for opposition 20 on 15^th Jun 2023	Examiner's First Report
Submitted for opposition 223 on 15^th Jun 2023	Total Provisional Refusal
Submitted for opposition 135 on 26^th Jan 2023	Amendment to Application
Submitted for opposition 256 on 26^th Dec 2022	Notification of Possible Opposition Sent
Submitted for opposition 257 on 24^th Feb 2022	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 23^rd Feb 2022	Created
Submitted for opposition 31 on 23^rd Feb 2022	Formalized
Submitted for opposition 228 on 14^th Jan 2022	International Registration
Submitted for opposition 30 on 14^th Jan 2022	Filed

ENGTR1S

Classification Information

Class [005]Gene therapy products, namely, engineered cell platforms for immunotherapy purposes; pharmaceutical preparations for use in the treatment of autoimmune diseases and disorders, autoinflammatory diseases and disorders, alloimmune diseases and disorders and allergic diseases and disorders.

Classification kind code

Class [040]Custom manufacture of pharmaceuticals for others; custom manufacturing and engineering of biological cells.

Classification kind code

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [005]
Gene therapy products, namely, engineered cell platforms for immunotherapy purposes; pharmaceutical preparations for use in the treatment of autoimmune diseases and disorders, autoinflammatory diseases and disorders, alloimmune diseases and disorders and allergic diseases and disorders.

Class [040]
Custom manufacture of pharmaceuticals for others; custom manufacturing and engineering of biological cells.